ClinicalTrials.Veeva

Menu

Tailored Intervention to Improve Patient Adherence to Secondary Stroke Prevention Medication

O

Odense University Hospital

Status

Completed

Conditions

Stroke
Transient Ischemic Attack

Treatments

Behavioral: Complex tailored intervention
Behavioral: Usual care

Study type

Interventional

Funder types

Other

Identifiers

NCT01684176
AKF-381

Details and patient eligibility

About

Patient suffering a Transient Ischemic Attack (TIA) or stroke are subsequently at high risk of a new stroke, however, poor adherence to secondary prevention medications occurs frequently within this patient group. The purpose of this study is to evaluate whether a complex tailored pharmacist intervention will lead to increased adherence to secondary stroke prevention medications and less new stroke events when compared to a usual care group. Interventions focus on motivational interviewing, medication review and telephone follow up.

Enrollment

211 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age: 18 years or older
  • Patient admitted or receiving ambulatory treatment for an acute transient ischemic attack or ischemic stroke which has occurred within the previous 30 days.
  • The patient or a carer usually dispenses the patient's medications
  • Written consent

Exclusion criteria

  • Cognitive or physical impairment that would preclude comprehension of a conversation
  • Terminal illness
  • Lives in a care home or an institution
  • Receives dose dispensed medicine from a pharmacy
  • Medicine is dispensed by a nurse in the patient's home
  • Correctional mental health patients

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

211 participants in 2 patient groups, including a placebo group

Complex tailored intervention
Experimental group
Description:
The intervention consists of 3 elements: 1. Medication review with recommendations focused on antithrombotics and adherence to guidelines and patient´s adherence to medications. 2. Discharge consultation with an pharmacist using motivational interviewing techniques. 3. Follow-up telephone calls one week, two months and six months after discharge.
Treatment:
Behavioral: Complex tailored intervention
Behavioral: Usual care
Usual care
Placebo Comparator group
Description:
Usual care
Treatment:
Behavioral: Usual care

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems